Last reviewed 2026-04-19 · How we verify

Advanced Prostatic Carcinoma

17 treatments

Approved treatments

Tryptorelin · Instituto Valenciano de Infertilidad, IVI VALENCIA
Delestrogen · Ph Health
Delestrogen works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen.
Lupron · Accord Healthcare S.L.U.
Leuprolide acetate, a long-acting GnRH analog, initially stimulates then suppresses pituitary gonadotropins, reducing gonadal steroid secretion.
Estrace · Pfizer
Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen.
Zoladex · Tersera
ZOLADEX inhibits pituitary gonadotropin secretion, leading to regression or inhibition of hormonally sensitive tumors.
Zoladex · Tersera
Zoladex works by mimicking the body's natural hormone to reduce testosterone production.
Lupron · Accord Healthcare S.L.U.
Lupron works by binding to and activating the gonadotropin-releasing hormone receptor, which ultimately leads to a decrease in the production of sex hormones.
Estring · Pfizer Inc.
Prevents pregnancy primarily by suppressing ovulation.
Vantas
Vantas works by binding to the gonadotropin-releasing hormone receptor, mimicking the natural hormone and reducing the production of sex hormones.
Depoestradiol · Pfizer
Leuprolide Acetate · Pfizer
Leuprolide acetate is a manufactured version of a hormone that regulates growth and development, used to treat hormone-related conditions.
Firmagon · Ferring
Firmagon works by blocking the action of gonadotropin-releasing hormone on the pituitary gland, which reduces testosterone production.
Trelstar · Verity
Trelstar works by binding to and activating the gonadotropin-releasing hormone receptor, which leads to a decrease in testosterone production.
Firmagon · Centre Leon Berard
Eligard · Astellas Pharma Europe Ltd.
Zoladex · University of Michigan Rogel Cancer Center
Triptoreline · Universitaire Ziekenhuizen KU Leuven

Clinical guidelines

FDA label — 1L
Leuprolide (Lupron) is indicated for the treatment of advanced prostate cancer.
FDA label — any
Leuprolide (Lupron) is indicated for the treatment of anemia due to bleeding uterine leiomyoma.
FDA label — any
Leuprolide (Lupron) is indicated for the treatment of endometriosis.
FDA label — any
Leuprolide (Lupron) is indicated for the treatment of precocious puberty.
FDA label — 1L
Not detailed in the provided text, but LUPRON DEPOT is indicated for advanced prostatic carcinoma.
FDA label — 1L
Not detailed in the provided text, but LUPRON DEPOT is indicated for precocious puberty.

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Advanced Prostatic Carcinoma patent landscape — cliff calendar, originator estates, attackable patents
Advanced Prostatic Carcinoma treatment landscape brief
Advanced Prostatic Carcinoma treatment updates RSS

Frequently asked questions about Advanced Prostatic Carcinoma

What drugs treat Advanced Prostatic Carcinoma?

Tracked treatments include Tryptorelin, Delestrogen, Lupron, Estrace, Zoladex, Estring, Vantas, Depoestradiol.

What is the treatment for Advanced Prostatic Carcinoma?

Standard treatment for Advanced Prostatic Carcinoma includes Tryptorelin, Delestrogen, Lupron, Estrace, Zoladex. See the treatment landscape page for first-line, second-line and salvage options.

What are the treatment guidelines for Advanced Prostatic Carcinoma?

FDA label publishes guidelines for Advanced Prostatic Carcinoma. 6 guideline references tracked.

Treatment landscape: Advanced Prostatic Carcinoma patent cliff · Advanced Prostatic Carcinoma CI report
Treatment: Tryptorelin · Instituto Valenciano de Infertilidad, IVI VALENCIA
Treatment: Delestrogen · Ph Health
Treatment: Lupron · Accord Healthcare S.L.U.
Treatment: Estrace · Pfizer
Treatment: Zoladex · Tersera
All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing